Micro- and nanotechnologies for quantitative biology and medicine

July 21, 2017

The August 2017 issue of SLAS TECHNOLOGY (formerly the Journal of Laboratory Automation) showcases 10 new reviews and original research reports that illustrate how the progression of research assays from qualitative outputs toward increasingly sensitive quantitative outputs is transforming life sciences and biomedical research and diagnostics by improving the ability of researchers and clinicians to detect and quantify increasingly complex assays.

Anchored by an in-depth, two-part review of digital assays by Amar S. Basu, Ph.D., of Wayne State University (Detroit, MI), the collection of papers presented in this special issue report improvements in assay design, such as data partitioning, and demonstrate how these improvements are enabling quantification of rare mutations in increasingly smaller sample volumes, quantitative single cell analysis of a range of other molecular biological outputs and more comprehensive analysis of heterogeneous populations as well as rare biological samples

Papers in this issue also share insight into how the integration of microfluidic technologies into all aspects of assay development, sample collection, sample trapping and detection is improving a wide range of life sciences and biomedical research applications. Examples include improved label-free detection of molecule-protein interactions with increased sensitivity as well as a 10x increase in array sample size by using flow cells in microscope slide; improved mechanobiological studies by improving control of external force input, such as regulation of extracellular matrix stiffness; improved tissue dissection and sample processing to improve analysis of smaller sample sizes in quantitative assays related to cancer diagnostics, developmental biology and drug screening.

Advances in quantitative analysis reported in this issue document accurate detection of species-specific ribosomal RNA through electrochemical biosensors to improve detection of blood bacterial infections; how sensor design can allow for equipment-free diagnostic devices against other infectious diseases with high sensitivity; and how current implementation of miniaturization technology paired with improved imaging analysis software allows for quantitative phenotypic analysis of increasingly complex samples, such as 3D spheroids, in high-throughput drug screening applications.
-end-
Visit SLAS TECHNOLOGY Online to read the special issue and listen to a podcast with author Amar S. Basu, Ph.D. SLAS TECHNOLOGY is one of two MEDLINE-indexed scientific journals published by SLAS. For more information about SLAS and its journals, visit http://www.slas.org/journals.

About our Society and Journals

SLAS (Society for Laboratory Automation and Screening) is an international community of more than 27,000 individual scientists, engineers, researchers, technologists and others from academic, government and commercial laboratories. The SLAS mission is to be the preeminent global organization providing forums for education and information exchange and to encourage the study of, and improve the practice of life sciences discovery and technology.

SLAS DISCOVERY: 2016 Impact Factor 2.444. Editor-in-Chief Robert M. Campbell, Ph.D., Eli Lilly and Company, Indianapolis, IN (USA). SLAS Discovery (Advancing Life Sciences R&D) was previously published (1996-2016) as the Journal of Biomolecular Screening (JBS).

SLAS TECHNOLOGY: 2016 Impact Factor 2.850. Editor-in-Chief Edward Kai-Hua Chow, Ph.D., National University of Singapore (Singapore). SLAS Technology (Translating Life Sciences Innovation) was previously published (1996-2016) as the Journal of Laboratory Automation (JALA).

Follow SLAS on Twitter at @SLAS_Org
Follow SLAS on Facebook at SocietyforLaboratoryAutomationandScreening
Follow SLAS on YouTube at SLASvideo
Follow SLAS Americas on LinkedIn at Society for Laboratory Automation and Screening (SLAS Americas)
Follow SLAS Europe on LinkedIn at Society for Laboratory Automation and Screening (SLAS Europe)

SLAS (Society for Laboratory Automation and Screening)

Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.